Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

videos

Videos
New Approaches to Treating Waldenström Macroglobulinemia
11/04/2019
Steven Treon, MD, PhD, FACP, FRCP, provided an update on the latest research in the treatment of Waldenström Macroglobulinemia.
Steven Treon, MD, PhD, FACP, FRCP, provided an update on the latest research in the treatment of Waldenström Macroglobulinemia.
Steven Treon, MD, PhD, FACP,...
11/04/2019
Oncology
Videos
What is the Role of P53 in Deciding a Treatment Approach for Relapsed MM?
11/01/2019
Shaji Kumar, MD, discussed the role of the P53 gene in deciding the best treatment approach for patients with relapsed MM.
Shaji Kumar, MD, discussed the role of the P53 gene in deciding the best treatment approach for patients with relapsed MM.
Shaji Kumar, MD, discussed the...
11/01/2019
Oncology
Videos
What is the Best Treatment Approach for Smoldering Myeloma?
10/25/2019
Joseph Mikhael, MD, MEd, FRCPC, explains the best treatment approach for patients with smoldering myeloma.
Joseph Mikhael, MD, MEd, FRCPC, explains the best treatment approach for patients with smoldering myeloma.
Joseph Mikhael, MD, MEd, FRCPC,...
10/25/2019
Oncology
Videos
Immunotherapies in Multiple Myeloma
10/25/2019
David E. Avigan, MD discusses active immunotherapies for the treatment of multiple myeloma.
David E. Avigan, MD discusses active immunotherapies for the treatment of multiple myeloma.
David E. Avigan, MD discusses...
10/25/2019
Oncology
Videos
Novel Therapies in AML
10/24/2019
Gail Roboz, MD, summarizes her presentation about novel therapies in AML at the 2019 Lymphoma & Myeloma Congress.
Gail Roboz, MD, summarizes her presentation about novel therapies in AML at the 2019 Lymphoma & Myeloma Congress.
Gail Roboz, MD, summarizes her...
10/24/2019
Oncology
Videos
Alternative Treatment Options for Older Patients With AML
10/23/2019
Sangmin Lee, MD, argued that venetoclax plus azacitidine, decitabine, and LDAC should not be the new standard care for older patients with AML.
Sangmin Lee, MD, argued that venetoclax plus azacitidine, decitabine, and LDAC should not be the new standard care for older patients with AML.
Sangmin Lee, MD, argued that...
10/23/2019
Oncology
Videos
Lymphoma & Myeloma Congress 2019: Chair Insights
08/13/2019
In this short video, 3 of the Lymphoma & Myeloma Congress Chairs share why their passion for the event is so strong.
In this short video, 3 of the Lymphoma & Myeloma Congress Chairs share why their passion for the event is so strong.
In this short video, 3 of the...
08/13/2019
Oncology
Videos
Genomic Testing and Tailored Therapies for Multiple Myeloma
12/13/2018
Joseph Mikhael, MD, MEd, FRCPC, spoke to Oncology Learning Network about genomic testing in multiple myeloma and how it can help clinicians personalize treatments for patients. He also shared his favorite analogy for using targeted therapy in...
Joseph Mikhael, MD, MEd, FRCPC, spoke to Oncology Learning Network about genomic testing in multiple myeloma and how it can help clinicians personalize treatments for patients. He also shared his favorite analogy for using targeted therapy in...
Joseph Mikhael, MD, MEd, FRCPC,...
12/13/2018
Oncology
Videos
Richard Furman, MD, Discusses Richter's Transformation and Emerging Therapies in CLL
11/08/2018
Dr Furman discusses disease progression with BTK inhibitor therapy, Richter's transformation, and emerging treatment options for CLL.
Dr Furman discusses disease progression with BTK inhibitor therapy, Richter's transformation, and emerging treatment options for CLL.
Dr Furman discusses disease...
11/08/2018
Oncology
Videos
Jonathon Cohen, MD, Discusses Treatment Options and Prognosis in MCL
11/08/2018
Dr Cohen discusses the available treatment options for patients with MCL, and describes methods for predicting patient response to specific therapies.
Dr Cohen discusses the available treatment options for patients with MCL, and describes methods for predicting patient response to specific therapies.
Dr Cohen discusses the available...
11/08/2018
Oncology

Advertisement

Advertisement

About

For nearly 2 decades, the Lymphoma, Leukemia & Myeloma Congress (formerly the Lymphoma & Myeloma Congress) has been recognized around the world as the most respected forum for industry-leading hematologic research.

It’s where interdisciplinary specialists convene to explore the controversial and the complex, the emerging and the exciting, and discuss, debate, and discover along the way.

This program features 4 days of comprehensive learning as we analyze emerging data, discover innovative treatment methods, and get a glimpse into the future of lymphoma, myeloma, and leukemia disorders.

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use